21st Annual Biotech in Europe Forum (BEF) (digital)
Basel Basel, SwitzerlandAbliva will attend the digital/hybrid event: 21st Annual Biotech in Europe Forum (BEF), on 7 - 8 October 2021.
Loading view.
Mitochondrial Diseases Conference 2021
VirtualItalian patient organization Mitocon arranges this year's Mitochondrial Diseases Conference in virtual. Abliva's Chief Medical Officer, Magnus Hansson, will give a flash presentation and join round table discussions at the meeting.
Kvinnokvällen (Women’s night) Malmö
VirtualAbliva will attend Aktiespararna's Kvinnokvällen Malmö, on 19 October 2021.. CEO Ellen Donnelly will be presenting the company at 7:30 p.m. CEST.
BioStock Life Science Summit
VirtualAbliva will attend the BioStock Life Science Summit 2021. CEO Ellen Donnelly will be presenting the company on 20 October at 2:00 p.m. CEST.
Mitochondrial Medicine – Therapeutic Development
VirtualAbliva will attend the virtual conference Mitochondrial Medicine - Therapeutic Development, organized by the Wellcome Connecting Science located at the Wellcome Genome Campus in the UK, on 30 Nov - 2 Dec 2021. Abliva's CMO, Magnus Hansson, has been invited to give a presentation on the topic Academia-pharma interplay in drug development, during Session 1: Mitochondrial […]
Mitochondria-Targeted Drug Development Summit
Hyatt Regency Boston/Cambridge 575 Memorial Dr, Cambridge, Massachusetts, United StatesAbliva will attend and present at the Mitochondria-Targeted Drug Development Summit in Boston, MA, USA. The event will be held on 22 - 24 February 2022. CEO Ellen Donnelly will be presenting in the session Patient-Focused Drug Development for Mitochondrial Disease. Synopsis: Highlighting the impact of patient input on research and development at Abliva Providing […]
Audiocast with teleconference
VirtualAbliva invites to a conference call and an online presentation on June 1, 2022, at 14:00 CEST. Abliva's CEO Ellen Donnelly, CMO Magnus Hansson and CFO Catharina Johansson will inform about the financing and implementation of KL1333 Phase 2/3 study and answer questions. The presentation will be held in English. After the presentation, there will […]
UMDF’s Mitochondrial Medicine Symposium
JW Marriott Phoenix Desert Ridge Resort & Spa Phoenix, AZ, United StatesAbliva will participate at the United Mitochondrial Disease Foundation's Mitochondrial Medicine Symposium in Phoenix, Arizona. Abliva's CMO, Magnus Hansson, will participate in a panel discussion on clinical trials together with Baylor College of Medicine, Cyclerion Therapeutics, and Khondrion, on Friday June 10.
Fireside Chat in Lund
Restaurang Inspira Scheeletorget 1, Lund, SwedenIn light of our recent announcement and the continued developments in the company, we would like to invite shareholders and interested investors to an informal gathering to hear more about the path forward directly from Ellen Donnelly (CEO) and the Abliva team. We hope you will join us in Lund during the Midsummer week to […]
Fireside Chat in Stockholm
Erik Penser Bank Apelbergsgatan 27, Stockholm, SwedenIn light of our recent announcement and the continued developments in the company, we would like to invite shareholders and interested investors to an informal gathering to hear more about the path forward directly from Ellen Donnelly (CEO) and the Abliva team. We hope you will join us in Stockholm during the Midsummer week to […]
Bioblast 2022: Inaugural Conference of Bioenergetics Communications
Congress Innsbruck Rennweg 3, Innsbruck, AustriaOn June 29-30, Abliva will participate at Bioblast 2022: Inaugural Conference of Bioenergetics Communications in Innsbruck, Austria. Abliva's Communications Officer & Lab Manager, Eleonor Åsander Frostner, will present a summary of the company's recent preprint publication "Towards a treatment for mitochondrial disease: current compounds in clinical development".
Aktiespararna’s Digital Temadag – Life Science
VirtualAbliva will be attending Aktiespararna's Digital Temadag - Life Science, on Aug 31, 2022. CEO Ellen Donnelly will present the company at 6:20 p.m. CEST. Follow link below for further information.